AllNewsPhotosVideos
Serum Institute Of India

Serum Institute Of India

Serum institute of india, Latest News

Serum Institute of India is a manufacturer of immunobiological drugs including vaccines in India. It was founded by Cyrus Poonawalla in 1966.The company is the world's largest vaccine producer by number of doses produced. It is currently developing an intra-nasal swine flu vaccine.
Read More
SII CEO Adar Poonawalla says Covovax to get approval as booster in 10-15 days - Hindi News | SII CEO Adar Poonawalla says Covovax to get approval as booster in 10-15 days | Latest national News at Lokmattimes.com

National :SII CEO Adar Poonawalla says Covovax to get approval as booster in 10-15 days

Serum Institute of India (SII) chief executive officer (CEO) Adar Poonawalla said its Covovax vaccine will get approval as ... ...

Maha govt demands 10 lakh Covishield shots from Centre - Hindi News | Maha govt demands 10 lakh Covishield shots from Centre | Latest maharashtra News at Lokmattimes.com

Maharashtra :Maha govt demands 10 lakh Covishield shots from Centre

Amid the rising Covid cases in many countries, there is anticipating growth in demand for Covid booster. The Maharashtra ... ...

Rising COVID cases news from China is concerning: SII CEO Adar Poonawala, urges people not to panic - Hindi News | Rising COVID cases news from China is concerning: SII CEO Adar Poonawala, urges people not to panic | Latest national News at Lokmattimes.com

National :Rising COVID cases news from China is concerning: SII CEO Adar Poonawala, urges people not to panic

Raising concern on the rising COVID-19 cases in neighbouring China, Serum Institute of India (SII) CEO Adar Poonawala on ... ...

HPV vaccine to prevent cervical cancer could be manufactured in India by April-May next year: Chief of medical panel - Hindi News | HPV vaccine to prevent cervical cancer could be manufactured in India by April-May next year: Chief of medical panel | Latest national News at Lokmattimes.com

National :HPV vaccine to prevent cervical cancer could be manufactured in India by April-May next year: Chief of medical panel

The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by ... ...

Posing as Adar Poonawalla, scammers dupe SII of Rs 1 cr, 7 nabbed - Hindi News | Posing as Adar Poonawalla, scammers dupe SII of Rs 1 cr, 7 nabbed | Latest national News at Lokmattimes.com

National :Posing as Adar Poonawalla, scammers dupe SII of Rs 1 cr, 7 nabbed

In a major breakthrough, the Pune Police said they have arrested seven accused in the cheating case in which ... ...

Covishield vaccine complication: Kerala HC issues notice to SII, state, Centre - Hindi News | Covishield vaccine complication: Kerala HC issues notice to SII, state, Centre | Latest health News at Lokmattimes.com

Health :Covishield vaccine complication: Kerala HC issues notice to SII, state, Centre

Kochi, Nov 18 The Kerala High Court on Friday issued a notice to the Serum Institute of India, ... ...

Production of HPV vaccine for cervical cancer to start in first quarter of 2023: Adar Poonawala - Hindi News | Production of HPV vaccine for cervical cancer to start in first quarter of 2023: Adar Poonawala | Latest national News at Lokmattimes.com

National :Production of HPV vaccine for cervical cancer to start in first quarter of 2023: Adar Poonawala

The production of India's first indigenously developed quadrivalent Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical cancer, by the Serum Institute of India will start in the first quarter of 2023 which got delayed due to ...

Adar Poonawalla says Serum Institute stopped Covishield production in Dec 2021 - Hindi News | Adar Poonawalla says Serum Institute stopped Covishield production in Dec 2021 | Latest health News at Lokmattimes.com

Health :Adar Poonawalla says Serum Institute stopped Covishield production in Dec 2021

The Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla said that vaccine manufacturer stopped the production ... ...